FT DIGITAL DIALOGUES | Building resilience in pharma R&D by decentralising and digitising
ON-DEMAND VIDEO NOW AVAILABLE
IN PARTNERSHIP WITH
This FT Digital Dialogue on Innovative Clinical Research Strategies, organised in partnership with ICON plc, discussed how to design and run more resilient trials in an uncertain world, where the need to decentralise is driving investment in new technology solutions and changing the pharma R&D landscape.
US Pharma and Biotech Correspondent
Chief Development Officer
EVP-Chief Medical Oficer
Senior Vice President, Patient, Site & Decentralised Solutions